Road from Research to Clinic: Could New CLL Treatments Be Available Soon? (Patient Power Interviews Dr Jeff Sharman at ASH2013)

[AussieNeil]

Andrew Schorr interviews Dr. Jeff Sharman, medical director of hematology research at The US Oncology Network, exploring the multitude of new and developing therapies for the treatment of CLL. Dr. Sharman provides an update about where we stand with recent approvals and emerging approaches--including monoclonal antibodies, combination therapies and BTK (Bruton's tyrosine kinase) inhibitors--and how these advances could impact survival.

patientpower.info/video/the...

Neil